2 results match your criteria: "GSF National Research Centre of Environment and Health[Affiliation]"
Evaluation of modified vaccinia virus Ankara as an alternative vaccine against smallpox in chronically HIV type 1-infected individuals undergoing HAART.
AIDS Res Hum Retroviruses
June 2007
Institute of Molecular Virology, GSF-National Research Centre of Environment and Health, Munich, Germany.
The fear of malevolent use of variola virus by terrorists has led to the implementation of a health care worker vaccination program and to the consideration of vaccination for the general public. However, due to concerns about side effects of the classical smallpox vaccine, especially for immunocompromised individuals, a safer vaccine is urgently needed. We characterized the immunogenicity of modified vaccinia virus Ankara (MVA), one of the more promising alternative smallpox vaccines, in a cohort of 10 chronically HIV-1-infected individuals undergoing highly active antiretroviral therapy (HAART).
View Article and Find Full Text PDFThe common non-synonymous variant G38S of the KCNE1-(minK)-gene is not associated to QT interval in Central European Caucasians: results from the KORA study.
Eur Heart J
February 2007
Institute of Human Genetics, GSF National Research Centre of Environment and Health, Ingolstädter Landstr. 1, D-85764 Neuherberg, Germany.
Article Synopsis
- The study aimed to investigate the relationship between the G38S variant in the KCNE1 gene and QT interval prolongation, which can lead to increased risk of sudden death.
- Researchers analyzed a group of 3,966 individuals from central Europe, finding no significant association between the G38S variant and QT interval in the overall sample or by gender.
- The conclusion suggests that, unlike another known variant, G38S may not significantly affect QT intervals, but its potential impact in different ethnic groups or under specific conditions can't be entirely dismissed.